SANTA CLARA, Calif. Highlights: Acquisition adds a differentiated portfolio and organizational capabilities in the fast-growing cell analysis market Combined portfolio expands cell-based applications and workflows allowing customers more choices to answer more questions from a single sample Combined clinical reagent and instrument portfolio allows for optimized complete solutions Expands R&D, Manufacturing & Operations, and Commercial

To read the full story...

Already a subscriber? Login now

< | >